Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.

Details

Language :

English

ISSN :

15384047

Volume :

16

Issue :

1

Database :

Academic Search Index

Journal :

Cancer Biology & Therapy

Publication Type :

Academic Journal

Accession number :

101047781

Full Text :

https://doi.org/10.4161/15384047.2014.987062